We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Tool Rapidly Analyzes Complex Cancer Images for Personalized Treatment

By LabMedica International staff writers
Posted on 05 Dec 2025

Complex digital biopsy images that typically take an expert pathologist up to 20 minutes to assess can now be analyzed in about one minute using a new artificial intelligence (AI) tool. More...

The technology can detect cancer, identify where tumor lesions are located, and estimate the proportions of regions with varying aggressiveness. It offers a faster, more informative way to interpret tissue samples and could support more personalized treatment decisions.

The AI model, developed by researchers at the University of Cambridge (Cambridge, England, UK), was trained only on slides labeled with basic diagnostic information rather than detailed annotations. Using Superpatch-based Measurable Multiple Instance Learning, the system analyzes whole-slide images to map cancer subtypes and grade distributions, even though it was trained without region-level guidance. By capturing the heterogeneous composition of tumors, the algorithm mimics how clinicians interpret complex tissue structures.

To evaluate performance, the team tested the model on eight datasets containing 3,850 whole-slide images representing lung, kidney, ovarian, breast, stomach, and prostate cancers. The study, published in Nature Cancer, showed that the tool delivered slide-level classification accuracy comparable to or better than nine leading AI systems. It also dramatically outperformed them in estimating tumor subtype proportions and spatial distribution across tissues.

These findings suggest that the tool could streamline diagnostic workflows and expand access to advanced cancer profiling. Because it trains on inexpensive, widely available datasets, it may help overcome cost barriers associated with spatial tumor mapping. The team now plans to apply the system to predict molecular biomarkers, providing deeper insights into tumor biology and enabling more tailored treatment strategies.

“By allowing pathologists to make faster, more accurate diagnoses, we can make sure patients receive the best treatment even sooner, improving our chances of successfully treating their cancer,” said Dr. Zeyu Gao, Early Cancer Institute, University of Cambridge, developer of the algorithm.

Related Links:
University of Cambridge


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new analysis of blood samples links specific protein patterns to five- and ten-year mortality risk (Photo courtesy of Adobe Stock)

Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention

Elevated levels of specific proteins in the blood can signal increased risk of mortality, according to new evidence showing that five proteins involved in cancer, inflammation, and cell regulation strongly... Read more

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.